Surviving Covid-19 with Heparin?

N Engl J Med. 2021 Aug 26;385(9):845-846. doi: 10.1056/NEJMe2111151. Epub 2021 Aug 4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / therapeutic use
  • COVID-19 / drug therapy*
  • Critical Illness
  • Dose-Response Relationship, Drug
  • Heparin / administration & dosage*
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / administration & dosage*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Thrombosis / prevention & control*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Heparin